-
Moore, CL, Stöhr, W, Crook, AM, Richert, L, Leliévre, J-D, Pantaleo, G, García, F, Vella, S, Lévy, Y, Thiébaut, R, et al.
Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions.
The Lancet HIV
6(5)
:
e334 -e340
2019
view publication
-
Mwasakifwa, GE, Moore, C, Carey, D, Amin, J, Penteado, P, Losso, M, Lim, P-L, Mohapi, L, Molina, J-M, Gazzard, B, et al.
Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy.
AIDS
32(3)
:
357 -361
2018
view publication
-
Yao, AH, Moore, CL, Lim, PL, Molina, J-M, Madero, JS, Kerr, S, Mallon, PW, Emery, S, Cooper, DA, Boyd, MA.
Metabolic Profiles of Individuals Switched to Second-Line Antiretroviral Therapy after Failing Standard First-Line Therapy for Treatment of HIV-1 Infection in a Randomized, Controlled Trial.
Antiviral Therapy
23(1)
:
21 -32
2018
view publication
-
Boyd, MA, Amin, J, Mallon, PWG, Kumarasamy, N, Lombaard, J, Wood, R, Chetchotisakd, P, Phanuphak, P, Mohapi, L, Azwa, I, et al.
Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
The Lancet HIV
4(1)
:
e13 -e20
2017
view publication
-
Moore, CL, Grulich, AE, Prestage, G, Gidding, HF, Jin, F, Petoumenos, K, Zablotska, IB, Poynten, IM, Mao, L, Law, MG, et al.
Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.
JAIDS Journal of Acquired Immune Deficiency Syndromes
73(5)
:
589 -597
2016
view publication